Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1983-3-17
|
pubmed:abstractText |
This contribution describes the essential rules underlying a valid estimation of FT4 and compares the way in which various methods deviate from ideal behaviour. The Amerlex FT4 RIA test has been validated by several approaches. A practical demonstration of the ability of various methods to correct for differences in T4-binding protein concentration has been made by independent studies in a UK hospital on euthyroid non-pregnant, euthyroid contraceptive and euthyroid pregnant women. The Amersham kit has been shown to correspond closely to theoretical expectations for FT4 values in these groups.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0029-5566
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
179-83
|
pubmed:dateRevised |
2007-1-12
|
pubmed:meshHeading | |
pubmed:year |
1982
|
pubmed:articleTitle |
Methodological background of the Amersham Amerlex free thyroxine RIA.
|
pubmed:publicationType |
Journal Article
|